-
research university and the recognized leader in experience-driven lifelong learning. Our world-renowned experiential approach empowers our students, faculty, alumni, and partners to create impact far beyond
-
the Institute for Mechanobiology (IfM) in Boston, MA (see https://mechanobiology.northeastern.edu/our-faculty for list of the IfM core faculty). This position has an initial 2-year appointment, renewable
-
research university and the recognized leader in experience-driven lifelong learning. Our world-renowned experiential approach empowers our students, faculty, alumni, and partners to create impact far beyond
-
that safeguard both clinical and non-clinical networks. This work will directly impact patient safety and digital resilience in some of the most vulnerable healthcare settings. Success in this role will help
-
adaptations], and global & country adaptations of budget impact analysis), and target patient population tools (US intended use and ex-US target patient population) Global HEOR launch activities In support of
-
of impact, including but not limited to: immigrant health, resilience in the context of syndemics, stress and resilience drivers of metabolic health, youth participatory action research, community needs
-
, and impact of a Medical Affairs department, both within the organization and in its interactions with the broader healthcare community. During the fellowship, participants will work on diverse projects
-
culture that fosters collaboration, growth, and innovative thinking - a place where you can make an impact and help change the standard of care in non-opioid pain management. Be part of our movement, let’s
-
, we are driven by just one goal - to lessen the severity and impact of influenza, which can reach epidemic or even pandemic proportions with life-threatening consequences. Every year our influenza
-
. About Chiesi Global Rare Diseases: Chiesi Global Rare Diseases is a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected by rare diseases. As a